Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., will establish a new U.S. headquarters, co-locating its commercial and development divisions in Basking Ridge, NJ. The move is part of an effort to create efficiencies and continue collaboration between the business segments for its existing and emerging therapeutic areas such as cardiology, oncology, pain and other areas.
 
Daiichi Sankyo, Inc. has U.S.-based development functions currently located in Edison, NJ, as well as U.S. commercial departments located in Parsippany, NJ. The new office will be located at 211 Mt. Airy Road, Basking Ridge. The company expects to begin moving employees to the new location in 2017.
 
“Uniting our New Jersey-based personnel into a single location not only makes us more efficient, but it will also further strengthen collaboration among teams working across the entire life cycle of our medicines,” said Dr. Glenn Gormley, chairman of the board and president, Daiichi Sankyo, Inc.  “We have enjoyed being a part of the Parsippany and Edison communities and we look forward to what the future holds in our new headquarters.”